PAR 5.36% 29.5¢ paradigm biopharmaceuticals limited..

Capital Raise, page-13

  1. 3,769 Posts.
    lightbulb Created with Sketch. 1548
    It really depends on how much is needed to finish off the phase III and what a realistic royalty % is. If a realistic percentage is 20% and we needed 100m to finish off the trial, a raise of $100m @ 20c would blow the shares on issue out by more than double, making a raise actually worse of than accepting half of the royalty.

    Whatever happens, it just needs to be in the best interests of shareholders.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.